SEC v. Henry Paul Regan, Jr., No. LR-26392, Southern District of New York (Sept. 9, 2025) — Press Release

U.S. SECURITIES AND EXCHANGE COMMISSION Litigation Release No. 26392 / September 9, 2025 Securities and Exchange Commission v. Henry Paul Regan, Jr., No. 1:25-CV-07343 (S.D.N.Y. filed Sept. 4, 2025) SEC Charges Former Stockbroker With Orchestrating $63 Million Offering Fraud On September 4, 2025, the Securities and Exchange Commission charged Henry Paul Regan, Jr. with defrauding hundreds of U.S.-based investors out of more than $63 million. The SEC’s complaint alleges that, from September 2022 through November 2024, Regan, while living in Colombia, solicited investors through selling promissory notes and partnership interests in companies affiliated with him, including, but not limited to, Next Level Holdings LLC, Yield Capital Management Inc., and Yield Wealth Ltd., that promised annual returns as high as 15.5% for 3- to 10-year terms. According to the complaint, Regan claimed he would pay these returns from profits generated by using investor funds to purchase and sell unrefined Colombian-sourced precious metals and by investing in health insurance policies issued under the Affordable Care Act, which Regan claimed generated monthly payments guaranteed by the federal government. In reality, instead of using investor funds for these stated purposes, Regan allegedly used most of the funds to make Ponzi-like payments to earlier investors, pay commissions to his network of salespeople, and wire funds to dozens of international companies. As alleged, in early fall of 2024, after media scrutiny on the offerings, firms and brokers ended their relationship with Regan’s companies, so that by November, Regan ceased paying and communicating with investors. The SEC's complaint, filed in the U.S. District Court for the Southern District of New York, charges Regan with violating Section 17(a) of the Securities Act of 1933 and Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder, and seeks injunctions, disgorgement, prejudgment interest, and penalties. In a parallel action, the U.S. Attorney’s Office for the Southern District of New York announced criminal charges against Regan. The SEC’s investigation was conducted by Michael F. McGraw and Brian R. Higgins, and supervised by Brendan P. McGlynn and Scott A. Thompson, all of the SEC’s Philadelphia Regional Office. The SEC’s litigation will be led by Christopher R. Kelly and supervised by Gregory R. Bockin, also of the SEC’s Philadelphia Regional Office. The SEC appreciates the assistance of the U.S. Attorney’s Office for the Southern District of New York and the FBI.

U.S. SECURITIES AND EXCHANGE COMMISSION Litigation Release No. 26392 / September 9, 2025 Securities and Exchange Commission v. Henry Paul Regan, Jr., No. 1:25-CV-07343 (S.D.N.Y. filed Sept. 4, 2025) SEC Charges Former Stockbroker With Orchestrating $63 Million Offering Fraud On September 4, 2025, the Securities and Exchange Commission charged Henry Paul Regan, Jr. with defrauding hundreds of U.S.-based investors out of more than $63 million. The SEC’s complaint alleges that, from September 2022 through November 2024, Regan, while living in Colombia, solicited investors through selling promissory notes and partnership interests in companies affiliated with him, including, but not limited to, Next Level Holdings LLC, Yield Capital Management Inc., and Yield Wealth Ltd., that promised annual returns as high as 15.5% for 3- to 10-year terms. According to the complaint, Regan claimed he would pay these returns from profits generated by using investor funds to purchase and sell unrefined Colombian-sourced precious metals and by investing in health insurance policies issued under the Affordable Care Act, which Regan claimed generated monthly payments guaranteed by the federal government. In reality, instead of using investor funds for these stated purposes, Regan allegedly used most of the funds to make Ponzi-like payments to earlier investors, pay commissions to his network of salespeople, and wire funds to dozens of international companies. As alleged, in early fall of 2024, after media scrutiny on the offerings, firms and brokers ended their relationship with Regan’s companies, so that by November, Regan ceased paying and communicating with investors. The SEC's complaint, filed in the U.S. District Court for the Southern District of New York, charges Regan with violating Section 17(a) of the Securities Act of 1933 and Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder, and seeks injunctions, disgorgement, prejudgment interest, and penalties. In a parallel action, the U.S. Attorney’s Office for the Southern District of New York announced criminal charges against Regan. The SEC’s investigation was conducted by Michael F. McGraw and Brian R. Higgins, and supervised by Brendan P. McGlynn and Scott A. Thompson, all of the SEC’s Philadelphia Regional Office. The SEC’s litigation will be led by Christopher R. Kelly and supervised by Gregory R. Bockin, also of the SEC’s Philadelphia Regional Office. The SEC appreciates the assistance of the U.S. Attorney’s Office for the Southern District of New York and the FBI.